Calypso Medical develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies.
Calypso Medical Technologies is a Seattle-based, privately held medical device company. The Company's proprietary tumor localization system utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed. The Company has strategic relationships with Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 8, 2007 | Series D | $42.20M | 2 | Apothecary Capital | — | Detail |
Jan 7, 2005 | Series C | $6.84M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Apothecary Capital | Yes | Series D |
Versant Ventures | — | Series D |